US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Labcorp Holdings Inc (LH)
Labcorp Holdings Inc (LH) ニュース

LH

Labcorp (LH)

Labcorp Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/25	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/25	05 : 16	PR Newswire (US)	Labcorp to Announce Third Quarter Financial Results on October 24, 2024	NYSE:LH	Labcorp Holdings Inc
2024/09/24	05 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/19	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/18	20 : 00	PR Newswire (US)	Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience	NYSE:LH	Labcorp Holdings Inc
2024/09/18	19 : 12	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:LH	Labcorp Holdings Inc
2024/09/17	07 : 35	PR Newswire (US)	LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034	NYSE:LH	Labcorp Holdings Inc
2024/09/17	06 : 30	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NYSE:LH	Labcorp Holdings Inc
2024/09/16	21 : 21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:LH	Labcorp Holdings Inc
2024/09/16	20 : 30	PR Newswire (US)	Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health	NYSE:LH	Labcorp Holdings Inc
2024/09/04	05 : 09	PR Newswire (US)	Labcorp to Speak at the Baird 2024 Global Healthcare Conference	NYSE:LH	Labcorp Holdings Inc
2024/08/09	23 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Labcorp Holdings Inc
2024/08/05	20 : 00	PR Newswire (US)	Labcorp Finalizes Acquisition of Select Assets of Invitae	NYSE:LH	Labcorp Holdings Inc
2024/08/02	21 : 30	PR Newswire (US)	Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx	NYSE:LH	Labcorp Holdings Inc
2024/08/01	19 : 57	PR Newswire (US)	Labcorp Announces 2024 Second Quarter Results	NYSE:LH	Labcorp Holdings Inc
2024/07/30	20 : 00	PR Newswire (US)	Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities	NYSE:LH	Labcorp Holdings Inc
2024/07/25	19 : 59	PR Newswire (US)	Labcorp Declares Quarterly Dividend	NYSE:LH	Labcorp Holdings Inc
2024/07/01	20 : 00	PR Newswire (US)	Labcorp to Announce Second Quarter Financial Results on August 1, 2024	NYSE:LH	Labcorp Holdings Inc
2024/06/17	21 : 00	PR Newswire (US)	Labcorp Launches Global Trial Connect to Accelerate Clinical Trials	NYSE:LH	Labcorp Holdings Inc
2024/06/10	21 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Labcorp Holdings Inc
2024/06/04	20 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/06/04	06 : 23	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NYSE:LH	Labcorp Holdings Inc
2024/06/03	20 : 00	PR Newswire (US)	Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio	NYSE:LH	Labcorp Holdings Inc
2024/05/31	02 : 18	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:LH	Labcorp Holdings Inc
2024/05/30	20 : 00	PR Newswire (US)	Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting	NYSE:LH	Labcorp Holdings Inc
2024/05/28	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/05/28	19 : 59	PR Newswire (US)	Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05 : 57	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05 : 45	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05 : 41	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NYSE:LH	Labcorp Holdings Inc

Showing the most relevant articles for your search:NYSE:LH

1 2 3 4 5 6 7 8 9 10 次へ >>

Franklin US Large Cap Mu...

Princeton Capital (PK)

Invesco Preferred Shares...

Kezar Life Sciences

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約